Date | Opp | DKSAL | FDSAL | DKFPTS | FDFPTS | min | fg% | fgm | fga | ftm | dd | fta | tfoul | 3pm | usg | 3pa | 3p% | 2pm | 2pa | pfoul | reb | ffoul | ast | fouls | stl | pace | blk | ft% | to | 2p% | pts | td | oreb |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-04-30 | vs. GS | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-04-28 | @ GS | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-04-26 | vs. GS | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-04-23 | @ GS | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-04-20 | @ GS | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-04-17 | vs. GS | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-04-15 | vs. GS | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-04-09 | @ DEN | $3K | $3.6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-04-07 | vs. GS | $3K | $3.6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-04-05 | @ DAL | $3K | $3.6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-04-04 | @ NO | $3K | $3.6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-04-02 | vs. SA | $3K | $3.6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-03-31 | @ POR | $3K | $3.6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-03-29 | @ POR | $3.1K | $3.6K | 1.5 | 1.5 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-03-27 | vs. MIN | $3.3K | $3.6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-03-25 | vs. UTA | $3K | $3.6K | 13 | 13.4 | 19 | 0.4 | 2 | 5 | 0 | 0 | 0 | 0 | 1 | 11.16 | 3 | 0.33 | 1 | 2 | 3 | 2 | 0 | 2 | 3 | 1 | 5 | 0 | 0 | 0 | 0.5 | 5 | 0 | 0 |
2023-03-24 | vs. PHO | $3K | $3.6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-03-21 | vs. BOS | $3K | $3.6K | 5 | 5 | 2 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 16.25 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 2 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 2 | 0 | 0 |
2023-03-20 | @ UTA | $3.2K | $3.6K | 0 | 0 | 3 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14.03 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-03-18 | @ WAS | $3K | $3.6K | 3.5 | 3 | 4 | 0.5 | 1 | 2 | 0 | 0 | 0 | 0 | 1 | 21.86 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 3 | 0 | 0 |
2023-03-16 | @ BKN | $3K | $3.6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-03-15 | @ CHI | $3K | $3.6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-03-13 | vs. MIL | $3K | $3.6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-03-11 | @ PHO | $3.2K | $3.6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-03-09 | vs. NY | $3.5K | $3.6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-03-06 | vs. NO | $3K | $3.6K | 5.5 | 5.4 | 15 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 11.93 | 3 | 0 | 0 | 1 | 1 | 2 | 0 | 2 | 1 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-03-04 | vs. MIN | $3K | $3.6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-03-03 | vs. LAC | $3K | $3.6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-02-28 | @ OKC | $3K | $3.6K | 5 | 3.5 | 13 | 0.25 | 1 | 4 | 1 | 0 | 2 | 0 | 1 | 20.87 | 3 | 0.33 | 0 | 1 | 2 | 0 | 0 | 1 | 2 | 0 | 7 | 0 | 0.5 | 2 | 0 | 4 | 0 | 0 |
2023-02-26 | @ OKC | $3K | $3.6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-02-24 | @ LAC | $3K | $3.6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-02-23 | vs. POR | $3K | $3.6K | 1.25 | 1.2 | 2 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 18.81 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-02-14 | @ PHO | $3K | $3.7K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-02-11 | vs. DAL | $3K | $3.7K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-02-10 | vs. DAL | $3K | $3.7K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-02-08 | @ HOU | $3K | $3.7K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-02-06 | @ HOU | $3K | $3.7K | 3 | 3 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-02-05 | @ NO | $3K | $3.5K | 16.75 | 15.2 | 18 | 0.5 | 2 | 4 | 2 | 0 | 2 | 0 | 1 | 16.33 | 2 | 0.5 | 1 | 2 | 1 | 1 | 0 | 6 | 1 | 0 | 7 | 0 | 1 | 2 | 0.5 | 7 | 0 | 0 |
2023-02-03 | @ IND | $3K | $3.5K | 1.5 | 1.5 | 8 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 9.9 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-02-01 | @ SA | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-01-30 | @ MIN | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-01-28 | @ MIN | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-01-25 | vs. TOR | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-01-23 | vs. MEM | $3K | $3.5K | 2.75 | 2.7 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-01-21 | vs. PHI | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-01-20 | vs. OKC | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-01-18 | @ LAL | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-01-15 | @ SA | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-01-13 | vs. HOU | $3K | $3.5K | 7.75 | 7.2 | 3 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 11.15 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 2 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 3 | 0 | 0 |
2023-01-11 | vs. HOU | $3K | $3.5K | 2 | 2 | 2 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 20.4 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 2 | 0 | 0 |
2023-01-09 | vs. ORL | $3K | $3.5K | 5 | 4.5 | 4 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 8.67 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 3 | 0 | 0 |
2023-01-07 | vs. LAL | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-01-04 | vs. ATL | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-01-03 | @ UTA | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2023-01-01 | @ MEM | $3K | $3.5K | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2022-12-30 | vs. UTA | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2022-12-28 | vs. DEN | $3K | $3.6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2022-12-27 | vs. DEN | $3K | $3.6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2022-12-23 | vs. WAS | $3K | $3.6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2022-12-21 | vs. LAL | $3K | $3.6K | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2022-12-19 | vs. CHA | $3K | $3.6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2022-12-16 | @ DET | $3K | $3.6K | 1.5 | 1.5 | 8 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 10.29 | 2 | 0 | 0 | 0 | 2 | 0 | 0 | 1 | 2 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2022-12-14 | @ TOR | $3K | $3.6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2022-12-13 | @ PHI | $3K | $3.6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2022-12-11 | @ NY | $3K | $3.6K | 9.5 | 10 | 13 | 0.33 | 1 | 3 | 0 | 0 | 0 | 0 | 0 | 12.54 | 2 | 0 | 1 | 1 | 2 | 0 | 0 | 4 | 2 | 1 | 4 | 0 | 0 | 1 | 1 | 2 | 0 | 0 |
2022-12-09 | @ CLE | $3K | $3.5K | 16.25 | 18.2 | 15 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 6.24 | 1 | 1 | 0 | 0 | 3 | 1 | 0 | 4 | 3 | 3 | 2 | 0 | 0 | 1 | 0 | 3 | 0 | 0 |
2022-12-07 | @ MIL | $3K | $3.5K | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2022-12-04 | vs. CHI | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2022-12-03 | @ LAC | $3K | $3.5K | 5.75 | 5.7 | 6 | 0.33 | 1 | 3 | 1 | 0 | 2 | 0 | 0 | 24.15 | 0 | 0 | 1 | 3 | 0 | 1 | 0 | 1 | 0 | 0 | 4 | 0 | 0.5 | 0 | 0.33 | 3 | 0 | 0 |
2022-11-30 | vs. IND | $3K | $3.5K | -0.5 | -1 | 7 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 20.44 | 1 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
2022-11-28 | vs. PHO | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2022-11-25 | @ BOS | $3K | $3.5K | 5 | 5 | 4 | 0.5 | 1 | 2 | 0 | 0 | 1 | 0 | 0 | 22.34 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 2 | 0 | 0 | 2.5 | 0 | 0 | 0 | 1 | 2 | 0 | 0 |
2022-11-23 | @ ATL | $3K | $3.5K | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2022-11-22 | @ MEM | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2022-11-20 | vs. DET | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2022-11-17 | vs. SA | $3K | $3.5K | 1.25 | 1.2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2022-11-15 | vs. BKN | $3K | $3.5K | 7.5 | 8 | 7 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 15.55 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 4 | 0 | 1 | 3 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
2022-11-13 | vs. GS | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2022-11-11 | @ LAL | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2022-11-09 | vs. CLE | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2022-11-07 | @ GS | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2022-11-05 | @ ORL | $1.5K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2022-11-02 | @ MIA | $3K | $3.5K | 10.5 | 9.9 | 19 | 0.4 | 2 | 5 | 0 | 0 | 0 | 0 | 1 | 16.32 | 1 | 1 | 1 | 4 | 4 | 2 | 0 | 1 | 4 | 1 | 6 | 0 | 0 | 2 | 0.25 | 5 | 0 | 1 |
2022-10-31 | @ CHA | $3K | $3.5K | 8 | 7.5 | 8 | 0.5 | 1 | 2 | 0 | 0 | 0 | 0 | 1 | 10.02 | 2 | 0.5 | 0 | 0 | 1 | 0 | 0 | 3 | 1 | 0 | 2 | 0 | 0 | 0 | 0 | 3 | 0 | 0 |
2022-10-29 | vs. MIA | $1.5K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2022-10-27 | vs. MEM | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2022-10-23 | @ GS | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2022-10-22 | vs. LAC | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2022-10-19 | vs. POR | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2022-10-14 | vs. LAL | $4K | $5K | 5.5 | 5.5 | 8 | 0.67 | 2 | 3 | 0 | 0 | 0 | 0 | 0 | 18.94 | 0 | 0 | 2 | 3 | 0 | 0 | 0 | 1 | 0 | 0 | 3 | 0 | 0 | 0 | 0.67 | 4 | 0 | 0 |
2022-10-12 | @ PHO | $4K | $5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2022-10-09 | vs. POR | $3.5K | $5K | 3.75 | 3.2 | 9 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 8.9 | 0 | 0 | 0 | 1 | 3 | 1 | 0 | 2 | 3 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 |
2022-10-03 | @ LAL | $4K | $5K | 7 | 6.9 | 9 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 8.72 | 1 | 0 | 0 | 1 | 1 | 2 | 0 | 3 | 1 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Matthew Dellavedova Daily Fantasy News, Rankings, Projections
Terence Davis (illness) questionable Friday. Alex Len (illness) and Matthew Dellavedova (illness) available to play.
Terence Davis (illness) questionable Friday. Alex Len (illness) and Matthew Dellavedova (illness) available to play.
Domantas Sabonis (illness) and Matthew Dellavedova (illness) ruled out Wednesday
Domantas Sabonis (illness) and Matthew Dellavedova (illness) ruled out Wednesday
Domantas Sabonis and Matthew Dellavedova (illness) downgraded to questionable Wednesday.
Domantas Sabonis and Matthew Dellavedova (illness) downgraded to questionable Wednesday.
Matthew Dellavedova (neck strain), Isaiah Hartenstein (concussion), Lamar Stevens (concussion), Collin Sexton (concussion), Larry Nance Jr. (fractured thumb), Dylan Windler and Taurean Prince all out Monday
Matthew Dellavedova (neck strain), Isaiah Hartenstein (concussion), Lamar Stevens (concussion), Collin Sexton (concussion), Larry Nance Jr. (fractured thumb), Dylan Windler and Taurean Prince have all been ruled out Monday when Cleveland takes on the Toronto Raptors. The Cavaliers will have ten active bodies so most players will offer increased value due to the minutes they will be forced to play. The main targets for the Cavs should be Darius Garland, Cedi Osman, Jarrett Allen, and Kevin Love. Isaac Okoro should round out the starting lineup and available off the bench are Dean Wade, Brodric Thomas, Damyean Dotson, Mfiondu Kabengele, and Jerimiah Martin.
Status update: Kevin Love and Matthew Dellavedova will remain on a minutes restriction Wednesday
Despite Love playing 31 minutes and Delly playing 34 minutes in the Cavs last game, coach Bickerstaff declared that both will still be on a minutes restriction against the Charlotte Hornets. Although this may be just coachspeak, it likely means that neither player will get in the high 30s. As Jarrett Allen and Larry Nance Jr. have returned, both players minutes may go down anyways.
Matthew Dellavedova on potential minutes restriction tonight that “could get lifted depending on how he plays/feels”
Matthew Dellavedova on potential minutes restriction tonight that “could get lifted depending on how he plays/feels”
Kevin Love (calf) and Matthew Dellavedova (abdominal) available to play Thursday
Coach Bickerstaff mentioned pre-game that both Love and Dellavedova would be available to play tonight against the Philadelphia 76ers. Love will reclaim his spot in the starting lineup, while Dellavedova should be available off the bench to play a few minutes. Both will have their minutes "monitored"; no specific minutes limit was listed, but it's unlikely either play gets past the 18-20 minute mark. With Love starting, Dean Wade will likely move to the bench and should take the biggest hit, while the Cavs other starters should lose some usage now that Love is available to play.
Matthew Dellavedova (abdominal) ruled out Sunday
Dellavedova hasn't been able to make his season debut all year, and although he was listed as questionable earlier, he was ultimately ruled out due to the abdominal injury that's cost him the whole season. Darius Garland and Colin Sexton should continue to play their heavy minutes as they have all year.
Larry Nance Jr. (rib) now listed as doubtful Saturday; Matthew Dellavedova (concussion) listed out
Nance Jr. has been listed as doubtful on the most recent version of the Cavaliers' injury report for Saturday's matchup against the Dallas Mavericks due to a rib contusion that has already forced him to miss three consecutive games, while Tristan Thompson went through shootaround and remains questionable to suit up with a sore left foot that’s kept him sidelined nearly two full months. In their absences, Ante Zizic has started the previous three contests at center, and he’s been solid from a fantasy perspective in an average of 30.4 minutes over that span. The Cavaliers are also slated to be without Matthew Dellavedova for a fifth straight contest, so his continued unavailability should allow Jordan Clarkson, Brandon Knight, and Nik Stauskas to still see extended run at their respective positions, though Stauskas could take on a diminished role if head coach Larry Drew opts to play bigger with Marquese Chriss absorbing some power forward minutes.
Larry Nance Jr. (rib) and Matthew Dellavedova (concussion) listed out Tuesday
Nance Jr. and Dellavedova have both been listed out on the most recent version of the Cavaliers' injury report and won't play in Tuesday's matchup against the Philadelphia 76ers due to a rib contusion and a concussion, respectively, while Tristan Thompson continues to be sidelined with a sore left foot. Additionally, Chriss was suspended one game by the NBA for his involvement in Monday’s altercation with Serge Ibaka and will serve the suspension in tonight’s contest, so with Kevin Love already deemed unavailable for rest purposes, the Cavaliers will find themselves extremely shorthanded in the frontcourt and will have just nine players active and available this evening. This means Ante Zizic will be needed to absorb a large portion of the available center minutes, and he’ll be a fine value option on tonight’s slate as long as he can avoid foul trouble against Joel Embiid, as he is averaging 1.13 DraftKings and 1.13 FanDuel points per minute with Love off the court since the All-Star break.